The role of fluoxetine on macrophage function in chronic pain (Experimental study in Balb/c mice)

Dwi Pudjonarko, Edi Dharmana, OS Hartanto


DOI: https://doi.org/10.12777/ijse.9.1.27-33

Abstract


Chronic pain raises stress conditions such as depression that can lower the cellular immunity. Fluoxetine is an antidepressant  used as an adjuvant in pain management but no one has been linked it with the body immune system. The objectives of this research were to proof the benefits of fluoxetine in  preventing degradation of macrophage function in chronic pain by measuring the macrophage phagocytic index , macrophage NO levels and the liver bacterial count in BALB/c mice infected with Listeria Monocytogenes.A Post Test - Only Control Group Design was conducted using 28 male mice strain BALB /c, age 8-10 weeks. The control group (C), mice got the same standard feed as the other groups. Chronic pain group (P), mice were injected with 20μL intraplantar CFA on day-1. Pain + fluoxetine early group (PFE) were treated with P + fluoxetine 5 mg / kg ip day-1, the 4th, the 7th and the 10th, while the Pain + fluoxetine late group (PFL) were treated with P + fluoxetine 5 mg / kg ip on day 7th and 10th. All mice were injected with 104 live Listeria monocytogenes iv on day 8th. Termination was performed on day 13th. Differences within groups  were analyzed using  One-way ANOVA and Kruskall Wallis, whereas the correlation of variables were analyzed using  Pearson's product moment. The experimental results showed that The macrophage phagocytic index and NO macrophage level (pg/mL) in PFE group(2,24±1,013; 0,24±0,239) was higher than than P group (1,68±0,920; 0,21±0,263) and there was no different in the macrophage phagocytic index of PFE group compared to C group (p=0,583; p=0,805). In PFL group (4,32±1,459; 0,54±0,294) the macrophage phagocytic index as well as NO macrophage level (pg/mL) was higher than P group (1,68±0,920; 0,21±0,263) with p=0,002; p=0,017. P group Bacterial count (log cfu/gram) (2,30±0,849) was significantly higher than C group(1,15±0,223) (p=0,007), while PFE group bacterial count (1,96±0,653) and PFL group bacterial count (1,84±0,403) compared to C (1,15± 0,223) was not significantly different (p=0,093; p=0,220). Correlation found between macrophage phagocytic index and macrophage NO (r=0,515, p=0,005).Macrophage phagocytic index and macrophage NO showed no correlation with bacterial count (r=-0,051, p=0,798; r=-0,071, p=0,719).It can be concluded that fluoxetine significantly incerases macrophage phagocytosis index and macrophages NO level in mice with chronic pain,  on the other hand fluoxetine decreases liver bacterial count . There is a positive correlation between macrophage phagocytosis index and macrophages NO level, while no correlation observed  among two variables with mice liver bacterial count in chronic pain.


Keywords


Chronic pain, fluoxetine, depression; phagocytic index; NO; bacterial count

Full Text:

FULL TEXT PDF

References


Breivik H, Collett B, Ventafridda V et al. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. European Journal of Pain. 2006; 10: 287–333.

Roper Public Affairs and Media. Americans living with pain survey: executive summary and results. Survey conducted on behalf of the American Chronic Pain Association. Last updated April 2004, cited February 2008. Available from: http://theacpa.org/documents/final pain survey results report.pdf.

Asghari A, Julaeiha S, Godarsi. Disability and Depression in Patients with Chronic Pain: Pain or Pain-Related Beliefs? Archives of Iranian Medicine. 2008; 11(3): 263 – 9.

Miller GE, Rohleder N, Stetler C, Kirschbaum C. Clinical Depression and Regulation of the Inflammatory Response During Acute Stress. Psychosomatic Medicine. 2005; 67:679–87.

Kurlekar PN, Bhatt JD. Study of the antinociceptive activity of fluoxetine and its interaction with morphine and naloxone in mice. Indian J Pharmacol. December 2004; 36(6): 369-72.

Press Release – FAA Propose New Policy on Antidepresant for Pilots.For Immediate Release, April 2, 2010. Available from: http://www.faa.gov/news/press_releases/news_story.cfm?newsId=11293.

Lindsey CW. The Top Prescription Drug of 2011 in United States: Antipsychotics and Antidepressants Once Again Lead CNS Therapeutics. ACS Chem Neurosci. 2012;3:630-1.

Suryamiharja A, Purwata TE, Suharjanti I, Yudianta, editor. Konsensus Nasional 1 Diagnostik dan Penatalaksanaan Nyeri Neuropatik. Kelompok Studi Nyeri, Perhimpunan Dokter spesialis Saraf Indonesia. 2011

Campbell DT, Stanley JC. Experimental and Quasi-Experimental Design for Research. Chicago: Rand McNally College Publishing Co, 1963. p. 25-7

Baron EJ, Peterson LR, Finegold SM. Diagnostic Microbiology, 9th edition. St. Louis: Mosby- Year book. Inc, 1990. p. 284-95.

Dieterd RR, Hotchkiss JH, Austic RE, Yen-Jen Sung. Production of Reactive Nitrogen Intermediates by Macrophages. In: Burleson GR, Dean JH, Munson AE, editors. Methods in Immunotoxicology, Vol 2. New York -Chichester-Brisbane-Toronto-Singapore: A John Willey & Sons. Inc, 1995. p. 99-117.

Silveira JW, Dias QM, Del Bel EA, Prado WA,. Serotonin receptors are involved in the spinal mediation of descending facilitation of surgical incision-induced increase of Fos-like immunoreactivity in rats. Mol. Pain. 2010; 6 -17.

Rahman W, D'Mello R, Dickenson AH. Peripheral nerve injury-induced changes in spinal alpha(2)-adrenoceptor-mediated modulation of mechanically evoked dorsal horn neuronal responses. J. Pain. 2008;9: 350-9.

Willis WD Jr. The somatosensory system, with emphasis on structures important for pain. Brain Res. Rev. 2007; 55: 297-313.

Ohayon MM, Schatberg AF. Using Chronic Pain to Predict Depressive Morbidity in the General Population. Arch Gen Psychiatry. 2003; 60: 39-47.

Checkley S. The neuroendocrinology of depression and chronic stress. Br Med Bull 1996; SPX 597-617.

Windle RJ, Wood SA, Kershaw YM, Lightman SL, Ingram CD, Harbuz MS. Increased corticosterone pulse frequency during adjuvant-induced arthritis and its relationship to alterations in stress responsiveness. Journal of Neuroendocrinology. 2001;13: 905–11.

Lightman SL. The neuroendocrinology of stress: a never ending story. Journal of Neuroendocrinology. 2008;20: 880–4.

Dickmeis T. Glucocorticoid and the circadian clock. Journal of Endocrinology. 2009;200: 3–22.

Padgett DA, Glaser R. How Stress influences the immune response. TRENDS in immunology August 2003; 24(8): 444-8.

Madden KS and Livnat S. Catecholamine action and immunologic reactivity. In: Ader R editor. Psychoneuroimmunology, 2nd ed. Academic Press,1991.

Marshall GD. Cytokine dysregulation associated with exam stress in healthy medical student. Brain behav immun 1998; 12: 297-307.

Chapman CR, Tuckett RP, Song CW. Pain and stress in a systems perspective: reciprocal neural, endocrine, and immune interactions. J. Pain. 2008; 9: 122-45.

Tracey I, Mantyh PW. The cerebral signature for pain perception and its modulation. Neuron. 2007; 55: 377-91.

Jensen TS, Yaksh TL. Comparison of the antinociceptive effect of morphine and glutamate at coincidental sites in the periaqueductal gray and medial medulla in rats. Brain Res. 1989; 476: 1-9.

Jacquet YF, Squires RF. Excitatory amino acids: role in morphine excitation in rat periaqueductal gray. Behav. Brain Res. 1988;31: 85-8.

Deakin JF, Dostrovsky JO. Involvement of the periaqueductal grey matter and spinal 5-hydroxytryptaminergic pathways in morphine analgesia: effects of lesions and 5-hydroxytryptamine depletion. Br. J. Pharmacol. 1978; 63: 159-65.

Ghazni NF, Cahill CM, Stroman PW. Tactile sensory and pain networks in the human spinal cord and brain stem mapped by means of functional MR imaging. AJNR Am. J. Neuroradiol. 2010;31: 661-7.

Oshiro Y, Quevedo AS, McHaffie JG, Kraft RA, Coghill RC. Brain mechanisms supporting spatial discrimination of pain. J. Neurosci. 2007;27: 3388-94.

Salomons TV, Johnstone T, Backonja MM, Shackman AJ, Davidson RJ. Individual differences in the effects of perceived controllability on pain perception: critical role of the prefrontal cortex. J. Cogn. Neurosci. 2007;19: 993-1003.

Seifert F, Maihofner C. Representation of cold allodynia in the human brain - a functional MRI study. Neuroimage. 2007;35: 1168-80.

Baliki MN, Chialvo DR, Geha PY, Levy RM, Harden RN, Parrish TB, et al. Chronic pain and the emotional brain: specific brain activity associated with spontaneous fluctuations of intensity of chronic back pain. J. Neurosci. 2006;26: 12165-73.

Frot M, Mauguiere F. Dual representation of pain in the operculo-insular cortex in humans. Brain. 2003;126: 438-50.

Tremblay P, Blier P. Catecholaminergic strategies for the treatment of major depression. Curr. Drug Targets. 2006;7: 149-58.

Guiard BP, Lanfumey L, Gardier AM. Microdialysis approach to study serotonin outflow in mice following selective serotonin reuptake inhibitors and substance P (neurokinin 1) receptor antagonist administration: a review. Curr. Drug Targets. 2006;7: 187-201.

De Gandarias JM, Echevarrıá E, Acebes I, Abecia L, Casis O, Casis L. Effects of fluoxetine administration on mu-opoid receptor immunostaining in the rat forebrain". Brain Research.1999;817 (1–2): 236–40.

Fox MA, Jensen CL, Murphy DL. Tramadol and another atypical opioid meperidine have exaggerated serotonin syndrome behavioural effects, but decreased analgesic effects, in genetically deficient serotonin transporter (SERT) mice. Int. J. Neuropsychopharmacol. 2009; 12: 1055-65.

Otsuka N, Kiuchi Y, Yokogawa F, Masuda Y, Oguchi K, Hosoyamada A. Antinociceptive efficacy of antidepressants: assessment of five antidepressants and four monoamine receptors in rats. J. Anesth. 2001;15: 154-8.

Korzeniewska-Rybicka I, Plaznik A . Supraspinally mediated analgesic effect of antidepressant drugs. Pol. J. Pharmacol. 2000;52: 93-9.

Korzeniewska-Rybicka I, Plaznik A . Analgesic effect of antidepressant drugs. Pharmacol. Biochem. Behav. 1998;59: 331-8.

Schreiber S, Pick CG. From selective to highly selective SSRIs: a comparison of the antinociceptive properties of fluoxetine, fluvoxamine, citalopram and escitalopram. Eur. Neuropsychopharmacol. 2006;16: 464-8.

Begovic A, Zulic I, Becic F. Testing of analgesic effect of fluoxetine. Bosn. J. Basic. Med. Sci. 2004;4: 79-81.

Singh VP, Jain NK, Kulkarni SK. On the antinociceptive effect of fluoxetine, a selective serotonin reuptake inhibitor. Brain Res. 2001;915: 218-26.

Yokogawa F, Kiuchi Y, Ishikawa Y, Otsuka N, Masuda Y, Oguchi K, et al. An investigation of monoamine receptors involved in antinociceptive effects of antidepressants. Anesth. Analg. 2002;95: 163-8.

Mahmood D, Akhtar M, Vohora D, Khanam R. Comparison of antinociceptive and antidiabetic effects of sertraline and amitriptyline on streptozotocin-induced diabetic rats. Hum. Exp. Toxicol. 2010;29: 881-6.

Duman EN, Kesim M, Kadioglu M, Yaris E, Kalyoncu NI, Erciyes N. Possible involvement of opioidergic and serotonergic mechanisms in antinociceptive effect of paroxetine in acute pain. J. Pharmacol. Sci. 2004;94: 161-5.

Duman EN, Kesim M, Kadioglu M, Ulku C, Kalyoncu NI, Yaris E. Effect of gender on antinociceptive effect of paroxetine in hot plate test in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2006;30: 292-6.

Pakulska W. Influence of sertraline on the antinociceptive effect of morphine, metamizol and indomethacin in mice. Acta Pol Pharm. 2004;61; 157-63.

Sounvoravong S, Nakashima MN, Wada M, Nakashima K. Modification of antiallodynic and antinociceptive effects of morphine by peripheral and central action of fluoxetine in a neuropathic mice model. Acta. Biol. Hung. 2007;58: 369-79.

Hasue RH, Shammah-Lagnado SJ. Origin of the dopaminergic innervation of the central extended amygdala and accumbens shell: a combined retrograde tracing and immunohistochemical study in the rat. J. Comp. Neurol. 2002;454: 15-33.

Nestler EJ. Under siege: The brain on opiates. Neuron. 1996;16: 897-900.

Wood PL. Opioid regulation of CNS dopaminergic pathways: a review of methodology, receptor types, regional variations and species differences. Peptides. 1983;4: 595-601.

Wood PL, Stotland M, Richard JW, Rackham A. Actions of mu, kappa, sigma, delta and agonist/antagonist opiates on striatal dopaminergic function. J. Pharmacol. Exp. Ther. 1980;215:697-703.

Schreiber S, Pick CG. From selective to highly selective SSRIs: a comparison of the antinociceptive properties of fluoxetine, fluvoxamine, citalopram and escitalopram. Eur. Neuropsychopharmacol. 2006; 16: 464-8.

Bhardwaj V, Kanagawa O, Swanson PE, Unanue ER. Chronic Listeria infection in SCID mice: requirements for the carrier state and the dual role of T cells in transferring protection or suppression. J Immunol. 1998; 160: 376–84.

Unanue ER. Inter-relationship among macrophages, natural killer cells and neutrophils in early stages of Listeria resistance. Curr Opin Immunol. 1997; 9: 35–43.

Neuenhahn M, Kerksiek KM, Nauerth M, Suhre MH, Schiemann M, Gebhardt FE, et al. CD8alpha+ dendritic cells are required for efficient entry of Listeria monocytogenes into the spleen. Immunity. 2006; 25: 619–30.

Corr S C, O’Neill LA. Listeria monocytogenes infection in the face of innate immunity. Cell Microbiol. 2009; 11: 703–9.

Condotta SA, Richer MJ, Badovinac VP, Harty JT. Probing CD8 T cell responses with Listeria monocytogenes infection. Adv immunol. 2012; 113: 51–80.

Serbina NV, Shi C, Pamer EG. Monocyte-mediated immune defense against murine Listeria monocytogenes infection. Adv immunol. 2012; 113: 119–34.

WirsingvonKoenig CH, Finger H, Hof H, Emmerling P. Postnatal development of resistance against infection in an experimental model. Zentralbl Bakteriol Orig A. 1978; 242(4): 547-54.

WirsingvonKonig CH, Heymer B, Finger H, Emmerling P, Hof H. Alteration of non-specific resistance to infection with Listeria monocytogenes. Infection. 1988; 16(2): S112–7.

Aoshi T, Carrero JA, Konjufca V, Koide Y, Unanue ER, Miller MJ. The cellular niche of Listeria monocytogenes infection changes rapidly in the spleen. European J immunol. 2009; 39(2): 417–25.

Carrero JA, Unanue ER. Mechanisms and immuno- logical effects of apoptosis caused by Listeria monocytogenes. Adv immunol. 2012; 113: 157–74.

Diacovich L, Gorvel JP. Bacterial manipulation of innate immunity to promote infection. Nat Rev Microbiol. 2010; 8(2): 117–28.

Flannagan RS, Cosıo G, Grinstein S. Antimicrobial mechanisms of phagocytes and bacterial evasion strategies. Nat Rev Microbiol. 2009; 7(5): 355–66.

Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol. 2007; 7(5): 379-90.

Bancroft GJ, Schreiber RD, Unanue ER. Natural immunity: a T-cell-independent pathway of macrophage acti- vation, defined in the scid mouse. Immunol Rev. 1991; 124: 5–24.

Pamer EG. Immune responses to Listeria monocytogenes. Nat Rev Immunol. 2004; 4 (10): 812–23.

Edelson BT, Unanue ER. Intracellularantibodyneutral- izes Listeria growth. Immunity. 2001; 14(5): 503–12.

Ladel CH, Flesch IE, Arnoldi J, Kaufmann SH. Studies with MHC-deficient knock-out mice reveal impact of both MHC I and MHC II-dependent T cell responses on Listeria monocytogenes infection. J immunol. 1994; 153(7): 3116–22.

Pearce EL, Shen H. Generation of CD8 T cell memory is regulated by IL-12. J immunol. 2007; 179(4): 2074–81.

Harty JT, Schreiber RD, Bevan MJ. CD8 T cells can protect against an intracellular bacterium in an interferon γ- independent fashion. PNAS. 1992; 89(23): 11612–16.

Shedlock DJ, Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science. 2003; 300(5617): 337–9.

Sun JC and Bevan MJ. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science. 2003; 300(5617): 339–42.

Hiromatsu K, Yoshikai Y, Matsuzakietal G. Aprotectiverole of γ/δ T cells in primary infection with Listeria monocytogenes in mice. JEM. 1992;175(1): 49–56.

Abbas AK, Lichtman AH, Pillai S. Cellular and Molecular Immunology. 6th Ed. Philadelphia: Elsevier Saunders Co, 2007.p 294-320.


Refbacks

  • There are currently no refbacks.


Published by Department of Chemical Engineering University of Diponegoro Semarang
Google Scholar

IJSE  by http://ejournal.undip.ac.id/index.php/ijse is licensed under Creative Commons Attribution 3.0 License.